- About Us
- Our Work
- Work With MSF
- Public Events
- Press Room
Learn more about the medical issues our patients face and see how MSF is responding.
MSF Response to the Final Amount of Funding Pledged at the Replenishment Meeting of the Global Fund to Fight AIDS, TB, and Malaria
MSF responds to the Global Fund's annoucement that it had received pledges totalling $12 billion for the next three years, falling short of its minimum target of $15 billion.
"Fighting Neglect" charts MSF's 25 years of experience in diagnosing and treating Chagas disease, sleeping sickness, and kala azar in Latin America, Sub-Saharan Africa, South Asia, and the Caucasus.
MSF shows the feasibility of implementing a mass vaccination campaign with oral cholera at the onset of an outbreak, using the results of a campaign conducted in Guinea in 2012.
But just as important gains are beginning to show their promise for patients, a stagnation in donor funding, coupled with trade policies that will create serious additional barriers to accessing affordable generic medicines, are dealing HIV/AIDS treatment a double blow.
MSF and other organizations are working to contain a deadly outbreak of Ebola hemorrhagic fever in northeastern DRC.
Mind the Deadly Gaps: Health Care Worker Shortages in Southern Africa Causing Fatal Delays in Bringing AIDS Care to Those in Urgent Need
Mexico City, 3 August 2008 – On the opening day of the XVII International Aids Conference, Médecins Sans Frontières (MSF) warned of the deadly impact that the lack of health care workers is having on AIDS treatment and care in southern Africa. In a satellite meeting called “Mind the Gaps” organized by MSF here today, experts described the scope and impact of the health care worker shortage as well as the critical need to increase government and donor commitment to taking immediate concrete steps to retain and support health care workers now.
In several countries where MSF works—such DRC, Guinea, Central African Republic, Nigeria, South Sudan and Myanmar—timely treatment remains out of reach for the majority of people who need it.
MSF calls on all state and non-state parties to the Syrian conflict to make immediate allowance for the delivery of humanitarian aid inside the country commensurate with the massive needs of the Syrian people.
Francis Gatluak's transformation from MSF patient to MSF nurse has saved countless lives.
Rosa Crestani, an MSF emergency coordinator just back from CAR, described the emergency response in Bouar in which she recently took part.
With malnutrition, it’s often just one, simple intervention that can change a child’s life forever. That was the case for a little boy named Tidjani, who came to our hospital gravely ill.
Working in a highly volatile security context, MSF has vaccinated some 26,000 children against measles and distributed basic supplies to thousands of people displaced by conflict.
Due to treatment from MSF and ceaseless support from his family, a 4-year-old boy in Tajikistan outlasted a form of TB few thought he would survive.
MSF psychologist and health advisor Ana Maria Tijerino describes the scale of the mental health needs in the Philippines, and how MSF is responding.
One month after Typhoon Haiyan hit the Philippines, MSF is providing health care for people in remote areas and supporting the health system as it recovers.
MSF is expanding activities to continue to treat the wounded and provide health services to about 14,000 people in two of the main sites for displaced people in Bangui following violence on December 5.
A new MSF project in the capital of Port Moresby is bolstering access to quality medical and psychosocial care.
MSF has completed a five-month screening project to combat sleeping sickness in DRC's Orientale Province.
First New TB Drug in Fifty Years Risks Being Squandered Without Better Research and Pricing Strategies
New TB drug bedaquiline illustrates the need for a paradigm shift in developing and ensuring access to new treatment combinations.
In this article, originally published on Huffington Post Impact, MSF Access Campaign executive director Dr. Manica Balasegaram argues for better access to vaccines.